If you need more lookups,
subscriptions start at $34 USD/month.
Mayur Amonkar Location
Collegeville, PA, US
Mayur Amonkar Work
2023 -now Associate Vice President, Real-World Evidence and Outcomes Research, Oncology at Merck and Co., Inc. @
2015 -2023 Executive Director, CORE Oncology @
2015 -2015 Senior Director, Worldwide Health Outcomes, Value and Access, Oncology @
2014 -2015 Head, Value Evidence and Outcomes - Oncology @
2007 -2014 Director, Global Health Outcomes @
2005 -2007 Senior Manager, Global Health Outcomes @
2003 -2005 Manager, Global Health Outcomes @
2002 -2003 Outcomes Research Scientist @ Pharmacia / Pfizer
1998 -2002 Assistant Professor @ West Virginia University - School of Pharmacy
Mayur Amonkar Education
West Virginia University
PhD (Health Outcomes)
1994-1997
The University of Toledo
MS (Pharmacy Administration)
1990-1992
KMK College of Pharmacy
BS (Pharmacy)
1985-1989
KC College 1983-1985
Cathedral & John Connon School 1972-1985
Mayur Amonkar Skills
Healthcare Management
Pharmacoeconomics
Health Economics
Outcomes Research
Clinical Research
Lifesciences
Clinical Trials
Market Access
Biotechnology
Pharmaceutical Industry
Life Sciences
Clinical Development
Pharmacy Benefit Management
Oncology
Global Health
Pharmacy
Managed Care
Drug Development
Neurology
Medical Affairs
Biostatistics
Molecular Biology
Project Management
Research
Mayur Amonkar Summary
Mayur Amonkar, based in Collegeville, PA, US, is currently a Associate Vice President, Real-World Evidence and Outcomes Research, Oncology at Merck and Co., Inc. at Merck & Co., Inc.. Mayur Amonkar brings experience from previous roles at Merck, Novartis Pharmaceuticals, GSK and GlaxoSmithKline. Mayur Amonkar holds a 1994 - 1997 PhD in Health Outcomes @ West Virginia University. With a robust skill set that includes Healthcare Management, Pharmacoeconomics, Health Economics, Outcomes Research, Clinical Research and more. Mayur Amonkar has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Mayur Amonkar?
Find contact details for 700 million professionals.